Midwest IPO GMP: ₹175 Peak → ₹110 Final → 9.39% Listing Gain Analysis
Midwest IPO GMP peaked at ₹175 (Oct 15), cooled to ₹110 final day, listed at ₹1,165 (+9.39%). Investors earned ₹16,310/lot.
GMP got direction right, magnitude wrong—classic pattern. Full breakdown below.
Table of Contents
What Is Midwest IPO GMP?
GMP, or Grey Market Premium, is the price at which IPO shares trade in an unofficial, unregulated market before the stock officially lists on an exchange.
It reflects how a particular company’s IPO might react on the day of listing — but it is not regulated by SEBI, NSE, or BSE. No broker, exchange, or government body oversees it.
Think of GMP as crowd-sourced investor sentiment — useful context, but never a guarantee.
For the Midwest IPO, the GMP became an active talking point because it moved significantly in the days leading up to listing.
Midwest IPO GMP Trend: Day-by-Day Breakdown
The Midwest IPO GMP made a high of ₹175 on October 16 against a low of ₹21 on October 11. That wide range illustrates exactly how volatile grey market prices can be.
Here’s how the GMP moved through the key dates:
| Date | GMP (₹) | Estimated Listing Price |
| October 11, 2025 | ₹21 | ~₹1,086 |
| October 15, 2025 | ₹175 | ~₹1,240 |
| October 16, 2025 | ₹175 | ~₹1,240 |
| October 17, 2025 | ₹110 | ~₹1,175 |
| Pre-listing (Oct 23) | ₹115 | ~₹1,180 |
On October 17 — the final subscription day — the GMP stood at ₹110, representing a 10.33% estimated premium over the issue price of ₹1,065.
The GMP cooled from its peak but remained firmly positive, which aligned with the actual listing outcome.
Midwest IPO: Key Details at a Glance
Before reading too much into GMP, it helps to understand what company is behind the numbers.
Midwest Limited is a Hyderabad-based company with over four decades of legacy in the dimensional natural stone industry. The company specialises in exploration, mining, processing, marketing, and export of natural stones.
In FY2025, Midwest held approximately 64% of India’s Black Galaxy Granite export market and accounted for 15.7% of national Absolute Black Granite production.
Here are the core IPO numbers:
| Detail | Value |
| IPO Open Date | October 15, 2025 |
| IPO Close Date | October 17, 2025 |
| Price Band | ₹1,014 – ₹1,065 per share |
| Lot Size | 14 shares |
| Minimum Investment (Retail) | ₹14,910 |
| Issue Size | ₹451 crore |
| Listing Date | October 24, 2025 |
| Listed On | NSE & BSE |
The company reported revenue of ₹643.14 crore in FY2025, up from ₹603.33 crore in FY2024. Profit rose to ₹133.30 crore from ₹100.32 crore — a healthy growth trajectory heading into the IPO.
Midwest IPO Subscription Status
A high GMP carries more weight when subscription data supports it. In this case, it did.
The Midwest Limited IPO was subscribed 87.99 times overall, receiving bids for 27,39,83,920 shares against 31,17,460 on offer.
Here’s the category-wise breakdown:
| Category | Subscription |
| QIB (Qualified Institutional Buyers) | 139.87x |
| NII (Non-Institutional Investors) | 168.07x |
| Retail Investors | 24.26x |
| Overall | 87.99x |
Strong NII and QIB demand is generally a more reliable signal than retail interest alone. Institutional and high-net-worth investors tend to do deeper due diligence. In this IPO, all three categories showed solid demand.
Did the Midwest IPO GMP Prediction Come True?

Mostly yes, but not perfectly.
The stock listed at ₹1,165 on NSE, reflecting a premium of 9.39% over the issue price of ₹1,065.. On BSE, it debuted at ₹1,165.10 — up 9.4% from the issue price. Investors who secured allotment made ₹16,310 per lot on listing day.
The final-day GMP of ₹110 had signalled roughly a 10–11% gain. The actual listing came in at 9.39% — close, but the peak GMP of ₹175 (implying ~16.5% gains) was clearly over-optimistic.
Before the official listing, unlisted Midwest shares were trading at ₹1,180 — a 10.80% premium. Even that final pre-listing figure slightly overstated reality.
This is a classic GMP pattern: directionally useful, rarely precise on exact magnitude.
What Happened After Listing?
Following the debut at ₹1,165, shares slipped to ₹1,137.20 on NSE — down 2.39% from the listing price — though allotted investors still booked a profit of ₹16,310 per lot.
Post-listing softness is common when an IPO lists at a meaningful premium. Profit-booking by allottees creates early selling pressure.
For long-term investors, the more relevant question is whether the business fundamentals justify holding beyond listing day.
Midwest reported an EBITDA margin of 25.76% and a debt-to-equity ratio of 0.43 for FY25 — indicating lean debt and reasonable profitability for a manufacturing and export-focused company.
How Is IPO GMP Calculated?

GMP is not officially calculated — it emerges from demand and supply in informal trades.
If a company prices its IPO at ₹1,065 and the grey market premium is ₹110, the estimated listing price is ₹1,175. Simple addition — but the reliability of that estimate depends entirely on market mood.
The key drivers of GMP movement include:
Company fundamentals — Strong financials and growth prospects push GMP higher.
Subscription levels — Day-by-day subscription data causes real-time GMP adjustments.
Market conditions — Broader Nifty/Sensex movement and sector sentiment affect appetite.
Anchor investor quality — Before the IPO, Midwest raised ₹135 crore in the anchor round from investors including Goldman Sachs Funds, Axis Mutual Fund, and Kotak Mutual Fund. High-quality anchor books tend to support and stabilise GMP.
Who Should Use GMP — and Who Should Be Cautious
GMP is useful when you:
- Want a quick pulse on market sentiment before listing.
- Are comparing it against subscription data to see if signals align.
- Are deciding whether to sell your Kostak application for a guaranteed smaller profit.
GMP becomes risky when you:
- Treat it as the primary or only reason to apply for an IPO.
- Ignore company financials, valuation, and sector risks.
- Expect the exact GMP figure to translate into listing gains.
IPO GMP is subject to extreme volatility. An investment decision based solely on Midwest IPO GMP — or any IPO GMP — carries real risk. Always consider the full picture.
Midwest IPO: Strengths and Risks
Strengths
- Near-monopoly position in Black Galaxy Granite exports (~64% market share).
- Integrated operations from mine to distribution.
- India’s granite production grew from 17,132 KT in FY2022 to 19,709 KT in FY2025 — a CAGR of ~4.7% — indicating a growing sector.
- Steady revenue and profit growth leading into the IPO.
- Strong anchor investor participation from institutional names.
Risks
- Granite exports are sensitive to global demand, especially from key markets like China and Europe.
- Mining operations face environmental and regulatory compliance risks.
- Some analysts viewed the IPO as aggressively priced at the upper band.
- Post-listing profit-booking pressure is a real near-term risk with oversubscribed IPOs.
Common Mistakes Investors Make With IPO GMP
Applying only because GMP is high. GMP reflects sentiment, not a business analysis. A high GMP in a weak market can collapse within hours of listing.
Ignoring category-wise subscription data. High retail subscription with weak QIB interest signals a very different risk profile than all three categories being strong.
Confusing Kostak rates with GMP. The Kostak rate is the amount one investor pays to the seller of an IPO application before listing — regardless of allotment. GMP is about per-share price. These are related but distinct concepts.
Not tracking GMP direction, only the number. A GMP that peaked at ₹175 and dropped to ₹110 by subscription close is a cooling signal — even if ₹110 still sounds positive.
Myths vs Facts: IPO GMP Edition
| Myth | Fact |
| High GMP guarantees listing gains | GMP is sentiment-based and can be wrong |
| GMP is regulated and reliable | GMP is completely unofficial and unregulated |
| Peak GMP = expected listing price | Peak GMP is often an over-optimistic spike |
| GMP is the same as Kostak | They are different — GMP is per share, Kostak is per application |
FAQs
What was the Midwest IPO GMP on the last subscription day? On October 17, 2025, the Midwest IPO GMP was ₹110, representing a 10.33% premium over the issue price of ₹1,065, with an estimated listing price of ₹1,175.
What was the Midwest IPO listing price? Midwest IPO listed at ₹1,165 on NSE and ₹1,165.10 on BSE — a premium of 9.39% over the issue price of ₹1,065.
How many times was the Midwest IPO subscribed? The Midwest IPO was subscribed approximately 88 times overall, with QIBs at 139.87x, NIIs at 168.07x, and retail investors at 24.26x.
Is GMP a reliable predictor of listing price? GMP is directionally useful — a positive GMP often means a positive listing — but the exact figure is rarely precise. Always cross-reference with subscription data and company fundamentals.
What is the difference between GMP and Kostak rate? GMP is the per-share premium in the grey market. The Kostak rate is the price at which you can sell your entire IPO application before allotment, regardless of whether you receive shares.
Where can I track live IPO GMP? Websites like InvestorGain.com, IPOWatch.in, and Chittorgarh.com track and update GMP daily for active and upcoming IPOs.
Analysis By: Ahmed | Hyderabad | 50+ IPOs tracked (2024-2026)
Sources: Chittorgarh, NSE, A2ZIPO, company RHP
Conclusion
The Midwest IPO GMP story is a textbook example of how grey market premiums work — and where they fall short.
The GMP swung from ₹21 to ₹175 and settled at ₹110 by close. The actual listing came in at ₹1,165 — a solid 9.39% gain, but well below the peak GMP hype. Allotted investors earned ₹16,310 per lot. Post-listing softness followed, as it often does with heavily subscribed issues.
The lesson is clear: GMP gets the direction right more often than not, but it rarely nails the magnitude — especially at peak readings.
Use Midwest IPO GMP data as one signal, not the only signal. Pair it with subscription trends, company fundamentals, valuation, and broader market conditions before making any investment decision.
Want to stay ahead of the next IPO? Visit our upcoming IPO tracker for live GMP updates, subscription status, and listing date alerts — before the next issue opens.

